APA (7th ed.) Citation

CM, D., S, S., SB, V., MC, U., & CS, D. (2025). Preclinical pharmacokinetics and in vitro ADME properties of PAT-1102: A novel HDAC inhibitor for cancer therapy. Journal of cancer research and clinical oncology, 151(5), 174. https://doi.org/10.1007/s00432-025-06227-5

Chicago Style (17th ed.) Citation

CM, Doreswamy, Seekallu S, Venkataramaiah SB, Umesh MC, and Devi CS. "Preclinical Pharmacokinetics and in Vitro ADME Properties of PAT-1102: A Novel HDAC Inhibitor for Cancer Therapy." Journal of Cancer Research and Clinical Oncology 151, no. 5 (2025): 174. https://doi.org/10.1007/s00432-025-06227-5.

MLA (9th ed.) Citation

CM, Doreswamy, et al. "Preclinical Pharmacokinetics and in Vitro ADME Properties of PAT-1102: A Novel HDAC Inhibitor for Cancer Therapy." Journal of Cancer Research and Clinical Oncology, vol. 151, no. 5, 2025, p. 174, https://doi.org/10.1007/s00432-025-06227-5.